Articles liés à Computational Drug Development Strategies to Target...

Computational Drug Development Strategies to Target HIV-1: A New Applications in Drug Discovery - Couverture souple

B., Babajan; Shaik, Noor Ahmad; M., Chaitanya

 
9783659327537: Computational Drug Development Strategies to Target HIV-1: A New Applications in Drug Discovery

Synopsis

In the battle between human antiretroviral drug therapy techniques and HIV-1 microevolution, HIV-1 is currently outpacing human antiretroviral drug therapy techniques: all treatments ultimately end in HIV-1 developing resistance to the treatment. Some scientists believe humans are pushing the microevolution of HIV-1 toward more resistant viruses. For example, some researchers claim that human drug therapies are accelerating retrovirus evolution through drug therapies that select for resistant viruses. Human intervention on HIV-1 evolution through drug therapies has also been accused of being detrimental to the ultimate goal of finding a permanent cure for HIV-1.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Présentation de l'éditeur

In the battle between human antiretroviral drug therapy techniques and HIV-1 microevolution, HIV-1 is currently outpacing human antiretroviral drug therapy techniques: all treatments ultimately end in HIV-1 developing resistance to the treatment. Some scientists believe humans are pushing the microevolution of HIV-1 toward more resistant viruses. For example, some researchers claim that human drug therapies are accelerating retrovirus evolution through drug therapies that select for resistant viruses. Human intervention on HIV-1 evolution through drug therapies has also been accused of being detrimental to the ultimate goal of finding a permanent cure for HIV-1.

Biographie de l'auteur

Dr. B. Babajan obtained his Ph.D., in Dept. of Biochemistry at Sri Krishnadevarya University. He is currently a Bioinformatic Scientist in PACER-HD at King Abdulaziz University, where he leads a group conducting research into Drug Discovery, SNP analysis, Genome Analysis and Computational Software's Development.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.